Cannell & Spears’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $551K | Hold |
25,595
| – | – | 0.01% | 279 |
|
|
2025
Q1 | $585K | Sell |
25,595
-400
| -2% | -$9.14K | 0.01% | 271 |
|
|
2024
Q4 | $675K | Sell |
25,995
-1,322
| -5% | -$34.3K | 0.01% | 266 |
|
|
2024
Q3 | $684K | Hold |
27,317
| – | – | 0.01% | 266 |
|
|
2024
Q2 | $585K | Sell |
27,317
-35
| -0.1% | -$750 | 0.01% | 257 |
|
|
2024
Q1 | $507K | Hold |
27,352
| – | – | 0.01% | 281 |
|
|
2023
Q4 | $444K | Hold |
27,352
| – | – | 0.04% | 143 |
|
|
2023
Q3 | $378K | Sell |
27,352
-1,450
| -5% | -$20K | 0.03% | 149 |
|
|
2023
Q2 | $637K | Sell |
28,802
-280
| -1% | -$6.19K | 0.05% | 117 |
|
|
2023
Q1 | $633K | Hold |
29,082
| – | – | 0.06% | 120 |
|
|
2022
Q4 | $529K | Hold |
29,082
| – | – | 0.05% | 127 |
|
|
2022
Q3 | $662K | Sell |
29,082
-270
| -0.9% | -$6.15K | 0.07% | 104 |
|
|
2022
Q2 | $405K | Buy |
29,352
+6,000
| +26% | +$82.8K | 0.04% | 146 |
|
|
2022
Q1 | $531K | Buy |
23,352
+209
| +0.9% | +$4.75K | 0.04% | 143 |
|
|
2021
Q4 | $863K | Buy |
23,143
+614
| +3% | +$22.9K | 0.06% | 110 |
|
|
2021
Q3 | $953K | Sell |
22,529
-4,102
| -15% | -$174K | 0.07% | 99 |
|
|
2021
Q2 | $1.19M | Sell |
26,631
-560
| -2% | -$24.9K | 0.09% | 92 |
|
|
2021
Q1 | $979K | Buy |
27,191
+48
| +0.2% | +$1.73K | 0.08% | 92 |
|
|
2020
Q4 | $1.08M | Buy |
27,143
+1,071
| +4% | +$42.7K | 0.09% | 88 |
|
|
2020
Q3 | $755K | Hold |
26,072
| – | – | 0.07% | 98 |
|
|
2020
Q2 | $426K | Buy |
26,072
+210
| +0.8% | +$3.43K | 0.04% | 130 |
|
|
2020
Q1 | $246K | Buy |
25,862
+7,795
| +43% | +$74.1K | 0.03% | 170 |
|
|
2019
Q4 | $292K | Buy |
18,067
+4,467
| +33% | +$72.2K | 0.03% | 149 |
|
|
2019
Q3 | $226K | Hold |
13,600
| – | – | 0.03% | 161 |
|
|
2019
Q2 | $231K | Hold |
13,600
| – | – | 0.03% | 159 |
|
|
2019
Q1 | $243K | Buy |
+13,600
| New | +$243K | 0.03% | 151 |
|